PCM
RDUS

Prelude Capital Management’s Radius Health, Inc. RDUS Stock Holding History

Prelude Capital Management’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-700
Closed -$14K – 2275
2019
Q1 		$14K Buy
700
+338
+93% +$6.17K ﹤0.01% 1369
2018
Q4 		$6K Sell
362
-382
-51% -$6.43K ﹤0.01% 1590
2018
Q3 		$13K Buy
+744
New +$16.8K ﹤0.01% 1412
2017
Q3 		– Sell
-328
Closed -$15K – 1978
2017
Q2 		$15K Buy
+328
New +$12.5K ﹤0.01% 1327
2016
Q2 		– Sell
-155
Closed -$5K – 1801
2016
Q1 		$5K Buy
+155
New +$5.36K ﹤0.01% 1204

Other funds holding RDUS

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Prelude Capital Management's RDUS Position: Q2 2019 in Review

Prelude Capital Management sold out of Radius Health, Inc. (RDUS) in Q2 2019, closing a stake of 700 shares — an estimated $14K sold.

Prelude Capital Management first reported a position in RDUS in Q1 2016 and held it in 5 quarters. The position peaked at $15K in Q2 2017. 124 funds tracked by Wall St. Rank hold RDUS as of Q2 2019.

  • Prelude Capital Management reported no remaining Radius Health, Inc. position as of Q2 2019 after selling out during the quarter.
  • Prelude Capital Management sold 700 Radius Health, Inc. shares in Q2 2019, an estimated $14K.
  • Prelude Capital Management first reported a position in Radius Health, Inc. in Q1 2016 and held it in 5 quarters.
  • Prelude Capital Management's Radius Health, Inc. position peaked at $15K in Q2 2017.
  • 124 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q2 2019.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.